BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 14, Issue 11
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (2385)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.
Item 
Count 
PDF45
WORD18
HTML1343
Tables (1-2)142
 Sum=1548
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse187
Download318
 Sum=505
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse79
Download178
 Sum=257
Nov 24, 2023 (publication date) through Jul 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Bhanderi H, Khalid F, Bodla ZH, Muhammad T, Du D, Meghal T. Autoimmune diabetes from pembrolizumab: A case report and review of literature. World J Clin Oncol 2023; 14(11): 535-543 [PMID: 38059185 DOI: 10.5306/wjco.v14.i11.535]
URL: https://www.wjgnet.com/2218-4333/full/v14/i11/535.htm
Number Citing Articles
1
Jose Angel Garcia, Diego Alcaraz, Esther Holgado, Felipe Couñago. Pembrolizumab autoimmune related diabetes: Moving forward, keep learning. World Journal of Clinical Oncology 2024; 15(5): 576-579 doi: 10.5306/wjco.v15.i5.576
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345